We have repeatedly suggested a strong likelihood that shares of Aphria Inc (OTCMKTS:APHQF) would start to ignite and move back into a leadership position in the cannabis rally now underway. You’ve got triple-digit topline growth and a solid balance sheet, along with a ton of investment in expanded market share over the past 12 months. The past two weeks has put that on display with a breakout back above the major moving averages.
Helping to fuel the action, the company just announced more international expansion to kick off this week in the form of a new strategic partnership with Schroll Medical, a subsidiary of prominent European flower producer, Schroll Flowers. According to the release, “The Partnership will pursue the cultivation and worldwide distribution of organic, EU GMP-certified medical cannabis, and will be managed by the Company’s wholly-owned subsidiary Aphria Deutschland GmbH. The deal accelerates Aphria’s global expansion, in collaboration with an established and world-class partner, with first product expected to be available by early 2019.”
Aphria Inc (OTCMKTS:APHQF) bills itself as a company that produces, supplies, and sells medical cannabis in Canada. Its cannabis products include dried flowers and cannabis oils. APHQF sells its products through its online store and telephone orders, as well as MMPR licensed producers.
The company offers sativa, indica, and hybrid medical marijuana products, as well as cannabis oils. It also provides support services in the form of medical consultations, group therapies, and rehabilitation to veteran and first responders.
The company sells its products through its online store or phones, as well as engages in the wholesale shipping of medical marijuana plant cuttings and dried buds to other licensed producers. Aphria Inc. is headquartered in Leamington, Canada.
According to press materials, “APHQF is one of Canada’s lowest cost producers, produces, supplies and sells medical cannabis. Located in Leamington, Ontario, the greenhouse capital of Canada. APHQF is truly powered by sunlight, allowing for the most natural growing conditions available. We are committed to providing pharma-grade medical cannabis, superior patient care while balancing patient economics and returns to shareholders. We are the first public licensed producer to report positive cash flow from operations and the first to report positive earnings in consecutive quarters.”
Find out when $APHQF reaches critical levels. Subscribe to OracleDispatch.com Right Now by entering your Email in the box below.
As noted above, APHQF shares have been quickly moving back into a solid leadership position since the stock sparked renewed momentum late last month. In all, the chart shows 76% tacked on to share pricing for the stock in the past month, a bounce that has taken root amid largely bearish action over the larger time frame.
In addition, the name has registered increased average transaction volume recently, with the past month seeing 260% above the average volume levels in play in this stock over the longer term.
“Aphria continues to execute on its strategy for international expansion, and we are pleased to have joined forces with a highly-regarded, experienced grower known around the world for its quality,” said Vic Neufeld, Chief Executive Officer at Aphria. “Our co-founders come from the world of commercial agriculture, including commercial flower production, so we speak the same language as Schroll and we bring to this Partnership the best-in-class know-how to produce high-quality, clean and pure medical cannabis for the worldwide market. Partnerships such as this continue to build upon Aphria’s foundation for long-term sustained growth in every market in which we operate.”
Earning a current market cap value of $3.29B, APHQF has a significant war chest ($59.7M) of cash on the books, which must be weighed relative to about $43.9M in total current liabilities. APHQF is pulling in trailing 12-month revenues of $36.9M. In addition, the company is seeing major top-line growth, with y/y quarterly revenues growing at 110.3%. As more color becomes clear on the name, we will review the situation and update our take. Sign-up for continuing coverage on shares of $APHQF stock, as well as other hot stock picks, get our free newsletter today and get our next breakout pick!
Disclosure: we hold no position in $APHQF, either long or short, and we have not been compensated for this article.